Yüklüyor......
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
The modulation of DNA repair pathways for therapeutic benefit in cancer has now become a reality with the development of poly (ADP-ribose) polymerase inhibitors (PARPi). PARP is involved in single-strand DNA breaks, which in the presence of defective homologous recombination repair lead to double-st...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3210467/ https://ncbi.nlm.nih.gov/pubmed/22084640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011417039 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|